654 related articles for article (PubMed ID: 17901710)
1. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values?
Bachorzewska-Gajewska H; Malyszko J; Sitniewska E; Malyszko JS; Pawlak K; Mysliwiec M; Lawnicki S; Szmitkowski M; Dobrzycki S
Kidney Blood Press Res; 2007; 30(6):408-15. PubMed ID: 17901710
[TBL] [Abstract][Full Text] [Related]
2. NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine?
Bachorzewska-Gajewska H; Malyszko J; Sitniewska E; Malyszko JS; Poniatowski B; Pawlak K; Dobrzycki S
Int J Cardiol; 2008 Jul; 127(2):290-1. PubMed ID: 17566573
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions.
Bachorzewska-Gajewska H; Malyszko J; Sitniewska E; Malyszko JS; Dobrzycki S
Am J Nephrol; 2006; 26(3):287-92. PubMed ID: 16772710
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
[TBL] [Abstract][Full Text] [Related]
5. NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine.
Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S
Adv Med Sci; 2009; 54(2):221-4. PubMed ID: 19875355
[TBL] [Abstract][Full Text] [Related]
6. Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention.
Liu XL; Wang ZJ; Yang Q; Yu M; Shen H; Nie B; Han HY; Gao F; Zhou YJ
Chin Med J (Engl); 2012 Mar; 125(6):1051-6. PubMed ID: 22613530
[TBL] [Abstract][Full Text] [Related]
7. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy].
Wang L; Pu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):301-4. PubMed ID: 24924456
[TBL] [Abstract][Full Text] [Related]
8. Serum neutrophil gelatinase associated lipocalin (NGAL) and cystatin C as early predictors of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.
Padhy M; Kaushik S; Girish MP; Mohapatra S; Shah S; Koner BC
Clin Chim Acta; 2014 Aug; 435():48-52. PubMed ID: 24804935
[TBL] [Abstract][Full Text] [Related]
9. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
Alharazy SM; Kong N; Saidin R; Gafor AH; Maskon O; Mohd M; Zakaria SZ
Angiology; 2014 May; 65(5):436-42. PubMed ID: 23580616
[TBL] [Abstract][Full Text] [Related]
10. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Pawlak K; Dobrzycki S
Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk.
McCullough PA; Williams FJ; Stivers DN; Cannon L; Dixon S; Alexander P; Runyan D; David S
Am J Nephrol; 2012; 35(6):509-14. PubMed ID: 22627273
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study.
Lebkowska U; Malyszko J; Lebkowska A; Koc-Zorawska E; Lebkowski W; Malyszko JS; Kowalewski R; Gacko M
Transplant Proc; 2009; 41(1):154-7. PubMed ID: 19249501
[TBL] [Abstract][Full Text] [Related]
13. Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography.
Shaker OG; El-Shehaby A; El-Khatib M
Angiology; 2010 Nov; 61(8):731-6. PubMed ID: 20529972
[TBL] [Abstract][Full Text] [Related]
14. Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease.
Malyszko J; Bachorzewska-Gajewska H; Poniatowski B; Malyszko JS; Dobrzycki S
Ren Fail; 2009; 31(10):910-9. PubMed ID: 20030526
[TBL] [Abstract][Full Text] [Related]
15. Renal function after percutaneous coronary interventions depending on the type of hydration.
Jarocka IT; Bachórzewska-Gajewska H; Kobus G; Czaban S; Małyszko J; Dobrzycki S
Adv Med Sci; 2013; 58(2):369-75. PubMed ID: 24285128
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography.
Filiopoulos V; Biblaki D; Vlassopoulos D
Ren Fail; 2014 Jul; 36(6):979-86. PubMed ID: 24673459
[TBL] [Abstract][Full Text] [Related]
17. Midkine: a novel and early biomarker of contrast-induced acute kidney injury in patients undergoing percutaneous coronary interventions.
Malyszko J; Bachorzewska-Gajewska H; Koc-Zorawska E; Malyszko JS; Kobus G; Dobrzycki S
Biomed Res Int; 2015; 2015():879509. PubMed ID: 25629054
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography.
Bachorzewska-Gajewska H; Malyszko J; Sitniewska E; Malyszko JS; Dobrzycki S
Nephrol Dial Transplant; 2007 Jan; 22(1):295-6. PubMed ID: 16951419
[No Abstract] [Full Text] [Related]
19. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S
Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771
[TBL] [Abstract][Full Text] [Related]
20. Renal effects of coronary artery bypass graft surgery in diabetic and non-diabetic patients: a study with urinary neutrophil gelatinase-associated lipocalin and serum cystatin C.
Arun O; Celik G; Oc B; Unlu A; Celik JB; Oc M; Duman A
Kidney Blood Press Res; 2015; 40(2):141-52. PubMed ID: 25832128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
